Acquisition of Emerald Health Therapeutics, Inc - Acquisition of Emerald Health Therapeutics, Inc., Narrative (Details) - Emerald Health Therapeutics Inc |
Nov. 10, 2022
USD ($)
shares
|
Dec. 31, 2022
USD ($)
|
Jul. 11, 2022
USD ($)
|
|---|---|---|---|
| Asset Acquisition [Line Items] | |||
| Net assets acquired, fair value | $ 15,045,412 | ||
| Qualifying asset | $ 1,536,275 | ||
| Exchange ratio | 1.95 | ||
| Equity interest issued or issuable (in shares) | shares | 416,270,514 | ||
| Affiliated Entity | Consulting Agreement | |||
| Asset Acquisition [Line Items] | |||
| Payable for obligations | $ 150 | ||
| Receivable | $ 22,542 |
| X | ||||||||||
- Definition Asset Acquisition, Assets Acquired and Liabilities Assumed, Gross No definition available.
|
| X | ||||||||||
- Definition Asset Acquisition, Exchange Ratio No definition available.
|
| X | ||||||||||
- Definition Asset Acquisition, Qualifying Asset No definition available.
|
| X | ||||||||||
- Definition Related Party Transaction Compensation Agreement Hourly Rate No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount receivable from related parties classified as other, due within one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|